YuanBio Venture Capital

YuanBio Venture Capital is a prominent venture capital firm specializing in the healthcare sector, particularly in biotechnology, medical devices, in vitro diagnostics, and healthcare services. Established in 2013 and headquartered in Suzhou, China, the firm has a global investment perspective, managing assets under management exceeding 10 billion RMB. Its portfolio comprises over 190 companies, with 19 listed on major stock exchanges, including the Shanghai Stock Exchange and Nasdaq.

The firm's investment strategy targets early and growth-stage companies, providing capital, management support, and operational assistance. YuanBio Venture Capital has demonstrated significant success, with several portfolio companies achieving substantial market valuations and international recognition. The firm's commitment to fostering innovation in the healthcare industry is evident through its diverse and expanding portfolio.

YuanBio Venture Capital's approach combines financial investment with strategic guidance, aiming to accelerate the growth of its portfolio companies. By leveraging its extensive network and industry expertise, the firm seeks to create value and drive advancements in the healthcare sector, both domestically and internationally.